The results of cementless tapered designed femoral stem were studied at a minimum 10-year follow-up in a non-selected, consecutive group of 27 patients (39 hips) with rheumatoid arthritis. Clinical and radiological analyses were performed in 27 hips, 17 patients (mean age at surgery 45 years) after a mean of 12 years. The postoperative Harris hip score was excellent for 14 hips, 9 hips were rated as good and 4 hips were fair or poor. No stem had to be revised for aseptic loosening. Proximal stress shielding was observed in 26 hips (96%); heterotopic ossiWcation was present in 11 hips (41%). Six hips required revision of the acetabular component. With uncemented tapered femoral Wxation excellent 12-year results are achieved in patients with rheumatoid arthritis.
Introduction
The total number of rheumatoid arthritis (RA) patients in total hip arthroplasty (THA) databases ranges from 3% (61,568 THA patients) in a United States cohort to 6% (93,852 THA patients) in the Swedish National Registry [1, 2] . A multidisciplinary approach is required for the management of these patients, with surgical procedures preferably undertaken by orthopaedic surgeons who are familiar with the speciWc problems of RA patients. While THA in patients with RA is known to greatly improve functional ability and thus self-support of the patient [3] , controversy remains among orthopaedic surgeons concerning the optimal Wxation of the implant [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
Cemented THA has traditionally been considered the gold standard for the treatment of patients with RA as poor bone stock caused by generalized disease activity, immobility and steroid therapy was thought to undermine primary stability and bony ingrowth of cementless implants [4, 6] .
Several studies have shown higher rates of loosening of cemented femoral components in patients with RA compared with cemented THA in patients with osteoarthritis (OA) [5, 15] . The Finnish Arthroplasty Register [7] found that the risk of stem revision due to aseptic loosening for patients with RA under the age of 55 (2,557 primary THA) was higher with cemented stems than with proximally porous-coated uncemented stems. Femoral failure rates of 5.3 and 8% after an average follow-up of 7.4-4.3 years have been reported with cemented THA for patients with RA [16, 17] .
Three long-term follow-up series with a single uncemented contemporary femoral component in patients with RA have been published. The results have been promising with revision rates between 0 and 1% after a mean followup of 8-10 years [9, 10, 14] .
We have retrospectively assessed the long-term clinical and radiological results (mean time of follow-up, 12.2 years; minimum 10 years) of a non-selected, consecutive series for patients with RA who all underwent cementless THA with the femoral component cementless system (CLS, Sulzer Medica, CH; now: Zimmer, Warsaw, Indiana, USA), in combination with one of Wve diVerent acetabular components.
Patients and methods
We performed 39 consecutive, unselected primary THA in patients with adult-onset RA using the CLS stem on 27 patients. All patients fulWled the diagnostic criteria of the American College of Rheumatology. For the follow-up analysis after a mean time of 12.2 years (minimum 10 years) there were 11 women (18 hips) and 6 men (9 hips) with an average age of 45.3 years (26-56) at time of surgery. Five patients (5 hips) were lost to follow-up and 5 patients (7 hips) had died prior to follow-up investigation. Prior to surgery 5 patients (8 hips) had been taking oral corticosteroids only, 3 patients (6 hips) took oral steroids and at least one disease-modifying rheumatic drug such as methotrexate; 9 patients (12 hips) had no medication at time of the index operation. No patient had received bone-modulating drugs during the entire period of follow-up. There were 4 patients (4 hips) rated as Charnely A, 1 patient (2 hips) as Charnely B and 12 patients (21 hips) as Charnely C [20] .
The CLS femoral component is a collarless, threedimensional tapered wedged made of titanium alloy (Ti 6 Al 7 Nb). Ribs in the proximal part of the prothesis are designed to minimize rotational migration. The distal part is intentionally made small to avoid Wlling of the intramedullary canal in the diaphysis in order to encourage proximal load transfer to the femur. The surface was rough blasted and had no porous coating [21] . All procedures were performed in staged settings by three diVerent senior surgeons in a closed air enclosure with laminar air Xow. All patients were placed in supine position and operated on with a direct transgluteal lateral Bauer approach [22] . The largest stem that provided a stable press-Wt was inserted after preparation of the femoral canal with chipped-tooth broaches.
Depending on availability and the surgeon's preference one of four diVerent cementless press-Wt acetabular components were used. There were seven Fitek cups with a metasul polyethylene (PE) liner (Zimmer, Warsaw, USA; before: Sulzer Medica, Wintherthur, Switzerland) 6 of which were Wtted with screws; 9 hydroxylapatite-coated and 4 zirconium-coated Phoenix cups (Brehm, Weisendorf, Germany) Wtted with PE-liners (Brehm, Weisendorf, Germany) in 11 cases and alumina inlays in 2 cases (Biolox, CermaTec, Plochingen, Germany); 1 Plasmacup (PE-inlay) Wxed with screws (Aesculap, Tuttlingen, Germany) and 1 Wagner cup (PE-inlay) (Zimmer, Warsaw, USA; before: Sulzer Medica, Wintherthur, Switzerland). Five acetabular components were cemented: in three cases acetabular reconstruction was required and a Ganz reinforcement ring (Zimmer, Warsaw, USA; before: Sulzer Medica, Wintherthur, Switzerland) was implanted in addition to the cemented metasul-PE cup (Zimmer, Warsaw, USA; before: Sulzer Medica, Wintherthur, Switzerland) and in two cases cemented PE-cups (Brehm, Wesiendorf, Germany) were used without acetabular reconstruction.
The femoral head size was 28 mm in 20 hips and 32 mm in 7 hips; there were 16 alumina ceramic (Biolox, CermaTec, Plochingen, Germany) and 11 CoCrMo-alloy (Metasul, Protek GmbH, Munich, Germany) heads. Due to the wide variety of acetabular implants used their performance was not the major target of this investigation.
All patients received prophylaxis for heterotopic ossiWcation by oral administration of 3 doses of 50 mg diclofenac for 2 weeks postoperatively. Routinely patients were given perioperative antibiotics (single shot of 2 g Cefazolin i.v.) and thromboembolism prophylaxis with subcutaneous heparin. Postoperatively, touch weight-bearing up to 15 kg was allowed for the Wrst 6 weeks, then progressively increased loading to full weight-bearing within the next 2 weeks. At the Wnal follow-up all patients were assessed clinically using the Harris hip score [23] . Preoperative pain, range of motion and function were reconstructed retrospectively by interview and patients charts.
Radiographs were evaluated by an independent observer (L.A.M) who was unaware of the clinical outcome of the surgical procedure. Evaluation of the femoral and acetabular components was performed using published criteria [24] . Radiological "stability" of the femoral component was additionally assessed according to the criteria of Engh et al. [25] . Location of radiolucent lines, osteolysis and cortical hypertrophy were rated according to the Gruen criteria [26] . For evaluation of heterotopic ossiWcation, the Brooker classiWcation was used [27] . Stress shielding was classiWed as grade I when only resorption of the medial edge of the resection line appeared, grade II meant additional proximal medial bone resorption, while grade III Wndings extended more distally [28, 29] .
Results
Of the 27 patients (39 hips) in this study, 5 patients (7 hips) had deceased at the time of the follow-up. Intermediate clinical and radiological follow-up of three patients (5 hips) ranging from 5 to 8 years of the deceased patients showed radiological signs of stable ingrowth of all stems without impending failures. There were two patients (2 hips) who had died with their hips intact but no clinical or radiological data beyond the 1-year follow-up at which time the implant was functioning well. Five patients (5 hips) were lost to follow-up, only a 2-month postoperative clinical and radiological follow-up was available with a well functioning hip (Fig. 1) .
Thus, clinical and radiological data were available for 17 patients (27 hips) after a mean of 12.2 years follow-up (minimum 10 years). There were ten women (18 hips) and seven men (9 hips) with an average age at surgery of 45.3 years (26-55). Of the 27 implants directly accounted for, no femoral component was revised and all stems had bony ingrowth. Five cups (19%) had to be revised due to aseptic loosening, for one additional cup the liner had to be changed due to extensive wear ( Table 1) .
The Harris hip score (HHS) was not taken preoperatively. Retrospective assessment of patient charts showed marked pain in all patients. Range of hip motion was limited to less than 110° in all cases; only six patients (35%) were able to walk without cane or crutches. At follow-up the average HHS was 86; 14 hips were rated as excellent (52%); 9, good (33%); and 4, fair (14%). Twenty-Wve hips (93%) had total relief from pain in the thigh, groin or buttocks. Two hips (7%) presented with occasional pain of the buttocks and the thigh. A Trendelenburg limp was found in one hip (4%) caused by a postoperative partial paralysis of the sciatic nerve after acetabular revision surgery. Thirteen patients (76%) could walk over 500 m, 4 patients (24%) walked outdoors under 500 m. Eleven patients (65%) needed no assistive devices for walking while two patients (12%) used a cane for outdoor walking only, three patients (18%) regularly used one cane.
No stem had to be revised for aseptic loosening and all stems presented complete bony ingrowth with no signs of deWnite or probable loosening. No postoperative subsidence was seen. Five stems were undersized, four in slight varus and two in minimal valgus position. Proximal stress shielding was observed in all hips. Bone resorption in the proximal portion of the femur (Gruen zones 1 and 7) , which was interpreted as grade II stress shielding, was present in 26 hips (96%), in one cases stress shielding extended to Gruen zones 2 and 6 (grade III). A non-progressive 4 £ 5 £ 5 mm osteolysis was seen in one patient (1 hip) located in Gruen zone 7, with 1-2 mm wear of the cemented PE-cup. In another case of suspected press-Wt cup loosening both stem and cup were intraoperatively found to be stable, a small proximal osteolysis in Gruen zone 7 was Wlled with autologous bone graft.
Radiolucencies of the stem without progression were found in three cases, all of which were located in the proximal Gruen zones I. Cortical hypertrophy was seen in three hips (11%) in Gruen zone 3 and 5. Twelve hips 45% developed a radiographic appearance of bone apposition at the tip of the stem. Heterotopic ossiWcation was present in 11 hips (41%): 8 hips (30%) grade I and 3 hips (11%) grade II.
With uncemented tapered femoral Wxation, excellent 12-year results are achieved in patients with rheumatoid arthritis (Fig. 2) .
Acetabular component
For 22 acetabular components (81%) Wxation was good without change in position. Five cups (19%; 4 press-Wt zirconium-coated Phoenix cups and one cemented PE-cup; Brehm, Weisendorf, Germany) had to be revised due to aseptic loosening, for one additional cup the liner had to be changed due to extensive wear (Table 1) . Of the 22 nonrevised acetabular components none showed signs of osteolysis and radiolucencies were seen in 1 hip (4%) in Zones II and III.
The amount of wear of the polyethylene liner or cup (n = 20 of the 22 non-revised hips) was analysed in increments of 1 mm maximum accuracy: <1 mm (1 hip, 4%), 1-2 mm (7 hips, 26%, 4 PE-liners, 3 metasul-PE liners).
The six hips which required isolated revision of the cup had radiographically bone-ingrown femoral components that were stable on examination during the operation. The radiological follow-up showed that these stems remained radiologically bone-ingrown. We observed no deep vein thrombosis, no luxation and no periprosthetic fracture in our cohort.
Discussion
In our non-selected, consecutive series of patients with RA who all underwent cementless THA the survival of the tapered designed stem has been excellent. No stem had to be revised and all showed signs of stable ingrowth after a mean follow-up of 12.2 years (minimum 10 years). Aseptic cup loosening was seen in four cases which had to be revised, additionally one liner had to be replaced due to extensive wear. Durable acetabular Wxations remains to be the major problem compromising the longevity of cementless THA for patients with RA.
The greater incidence of acetabular and femoral loosening after cemented THA for patients with RA compared to those with OA [5, 12, 15, 17, 18, 30] has been attributed to periacetabular and generalized osteoporosis related to disease activity, steroid therapy and immobility [6, 31, 32] . As for elderly patients with OA, the hypothesised poorer bone stock of patients with RA has been the main argument for cemented THA.
The increasing number of investigations with promising results for cementless THA for patients with RA [4, [8] [9] [10] [11] 13] has recently been conWrmed by a study of the Finnish Arthroplasty Register [7] for the femoral component, while for the acetabulum cemented all-polyethylene cups were the implant of choice (Table 2) .
Three long-term follow-up series with a single uncemented contemporary femoral component in patients with RA have been published: Lybäck et al. [14] reported an excellent 10-year survival rate of 100% (with aseptic loosening as an endpoint) for a group of 55 patients (77 hips) with juvenile chronic arthritis (mean age at operation 28 years) who had received the proximally circumferentially porous-coated Bi-metric stem. For another proximally circumferentially porous-coated uncemented stem (Biomet Taperloc) Keisu et al. [10] reported no revision and no signs of radiological loosening after a mean follow-up of 8 years in group of 39 patients (50 hips) with adult-onset RA (mean age at operation 55 years). Jana et al. [9] reported of 55 patients (71 hips) with adult-onset RA (mean age at operation 55.1 years) after a mean follow-up of 11.2 years with 1 stem revised and an additional 4 stems showing radiological signs of loosening (porous-coated Anatomic Medullary Locking stem).
It is well published, that for patients with OA of the hip joint, tapered designed uncemented stems achieved excellent clinical and radiological results at 10 years postoperatively [33] [34] [35] . SpeciWcally with the CLS stem used in the present patient cohort, we have observed similar excellent results for 94 patients (107 hips) with OA (mean age at operation 51 years) after a mean follow-up of 10.3 years, no stem had to be revised and radiological stable ingrowth was observed in 95% of the radiographically analysed cases [35] .
Our single femoral implant, single surgeon series is the Wrst with a mean 12.2 year (minimum 10 years) follow-up for tapered designed uncemented stems in patients with RA and only the second publication thus far with an above mean 10-year results for uncemented stems of patients with adult-onset RA. We recognize that our study is limited by the relatively small patient cohort and the retrospective nature of our investigation. Furthermore, our series is nonrandomised, thus no direct comparisons with a cemented group is possible. Nevertheless, we managed to account for all but Wve of the patients still alive of this series. Even though no match of the presented RA group was possible with an osteoarthritic control group, the number of stem revisions and stable radiological ingrowth with the same implant show equally excellent results for both groups in our hospital [35] .
All published short-and long-term data with a single contemporary uncemented femoral component for patients with juvenile and adult-onset RA conWrm the encouraging [4, [8] [9] [10] [11] 13] underlined by the report of the Finnish Arthroplasty Register [7] who analysed 2,557 THA for RA in younger patients and found favourable results for uncemented femoral implants.
The chronic course of RA with multiple aVected joints of the lower limbs aVected, makes the clinical evaluation of a speciWc surgical procedure diYcult to interpret. While excellent clinical results after THA were reported by Keisu et al. [10] with a relatively high HHS of 93 (follow-up mean, 8 years; mean age at operation, 55 years) and 32% of their patients classiWed according to Charnley as grade C, Jana et al. [9] found the Merle D'Aubigné and Postel walking score (follow-up mean, 10 years; mean age at operation, 55.1 years) to improve in only 61% of their patients, 20% had lower scores. Even though 12 patients (21 hips, 78%) of our patients were rated as Charnely C, we found satisfying clinical results with an average HHS of 86 at follow-up. All patients reported clinical improvement with reduced pain and increased walking distance.
Keisu et al. [10] noted postoperative mild thigh pain in only 2.2% of his RA patients after cementless THA with the titanium alloy, circumferential plasma spray coated, Taperloc femoral stem. Accordingly, we observed two patients who presented with occasional thigh pain. With the same implant in the same clinic and a comparable mean follow-up time, thigh pain was observed only for patients with OA in cases of radiologically loose, but not yet revised acetabular components. Whether the low incidence of thigh pain compared to other cementless implants [36, 37] is due to the tapered geometry that is believed to distribute stress over a larger area remains speculative [10, 38] .
No case of superWcial or deep wound infection was seen in our series. While for all patients who had taken oral corticosteroids preoperatively the dose was increased perioperatively and administered intravenously to avoid an Addison-crisis, other immunosuppressing drugs such as MTX were paused 2 weeks prior to surgery until deWnite wound healing (2 weeks postoperatively) was reached. No clear consensus exists on whether methotrexate (MTX) should be continued or whether this therapy should be discontinued for a few weeks in patients with rheumatoid arthritis (RA) undergoing surgery. Pieringer et al. [39] analysed the current literature according to which continued MTX therapy appears to be safe perioperatively and seems also to be associated with a reduced risk of Xares, even though none of examined papers addressed the issue of safety in connection with comorbidities. Our series is too small to make any conclusion on the observed rate of infection and the inXuence of discontinuing MTX therapy perioperatively.
Radiographic evidence of bone ingrowth of the stem in our series (100%) is equal to the radiographic results of Keisu et al. [10] (100% radiographic evidence of bone ingrowth). Despite reporting an increased polyethylene wear rate Keisu et al. [10] observed no case of proximal or distal femoral osteolysis. They believed that the circumferential plasma spray coating in combination with the 100% rate of proximal bone ingrowth of the Taperloc titanium alloy femoral stem protected the femoral canal from PEdebris and thus osteolysis [10] .
Despite polyethylene particulate debris, osteolysis and radiolucencies were never of clinical or radiological signiWcance for the femoral component in our investigation. Schramm et al. [35] reported wear of the polyethylene liners of <1 mm (56%), 1-2 mm (29%), >2 mm (5%), for patients with osteoarthritis of the hip joint (mean time of follow-up 10.3 years, mean age at operation 51 years) who had received the same prosthesis in the same clinic with an identical polyethylene liner. Even though our cohort was slightly younger and our mean follow-up an average 2 years longer, we observed less PE-wear [<1 mm (1 hip, 4%), 1-2 mm (7 hips, 26%, 4 PE-liners, 3 metasul-PE-liners] which we believe is due to the lower physical demand of RA patients.
Even though acetabular components were not the major target of this investigation due to the wide variety of acetabular implants used, their performance was considered good. The four revised press-Wt cups were all zirconium coated and prone to aseptic loosening caused by debonding of the zirconium from the cup. None of the non-zirconium coated press-Wt cups had to be revised or showed radiological signs of loosening at follow-up.
The results of cementless THA for young patients with rheumatoid arthritis are very promising and comparable to patients with OA. Durable femoral and acetabular Wxation was achieved. Slight undersizing, varus and valgus positioning of the stem did not undermine good clinical results after a mean 12.2-year follow-up.
